TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.00680nMAssay Description:Binding affinity to BMP1 (unknown origin) using ((5-FAM)-ELIDQYDVQRDDSSDGSLED-K(5,6 TAMRA)-CONH2 as substrate preincubated for 3 hrs followed by subs...More data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.0400nMAssay Description:Binding affinity to BMP1 (unknown origin) using ((5-FAM)-ELIDQYDVQRDDSSDGSLED-K(5,6 TAMRA)-CONH2 as substrate preincubated for 3 hrs followed by subs...More data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 7nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 8nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 11nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 14nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 18nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 22nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 28nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 33nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 35nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 40nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 43nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 63nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 64nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 86nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 90nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 98nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 105nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 110nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 120nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 160nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 190nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 200nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 210nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 250nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 260nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 280nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 300nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 330nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 340nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 340nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 350nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 400nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 410nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 410nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 470nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 470nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 480nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 530nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 530nMAssay Description:In vitro inhibitory activity against procollagen C-terminal proteinase (PCP) in HT-1080 cells using synthetic peptide as substrateMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 620nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 660nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair
TargetBone morphogenetic protein 1(Homo sapiens (Human))
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Glaxosmithkline Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 740nMAssay Description:Ability to inhibit procollagen C-terminal proteinase (PCP) tested in vitroMore data for this Ligand-Target Pair